News

Invited to attend investor conference, GeneFerm Biotechnology released the new growth engine.
Invited to attend investor conference, GeneFerm Biotechnology released the new growth engine.
| 2022-12

GeneFerm Biotechnology's Nanke factory plant 2 will be starting mass production in 2023. In recent years, precision fermentation industry is booming worldwide along with the increasing demand of professional advice. GeneFerm will offer professional CDMO service based on our mass production technology and experience, achieving another peak on our sales performance.

More
The completion of GeneFerm Biotechnology’s new plant. Precision fermentation is ready to go.
The completion of GeneFerm Biotechnology’s new plant. Precision fermentation is ready to go.
| 2022-11

GeneFerm Biotechnology expanded Nanke factory plant with the new Plant 2, which was open in November, 2022. Equipped with two 66,000-liter/66-ton fermenter and related purification facilities, we are able to undertake increased order volume, as well as precision fermentation development and mass production of new products.

More
Anti-Additive Clean Label Certificated. Sustainable health affirmed.
Anti-Additive Clean Label Certificated. Sustainable health affirmed.
| 2022-11

Congratulations to GeneFerm Biotechnology for obtaining A.A. clean label certification for it's product "Ganoderma lucidum polysaccharides composite composition drink". Through third-party supervision mechanism and cleanliness enhancement as social responsibility, we strengthen our production standards, continue to develop healthy, sustainable and high-quality functional products with good flavor for all consumers.

Won the international Quality Award From Monde Selection® lnstitute
Won the international Quality Award From Monde Selection® lnstitute
| 2022-06

Congratulations to GeneFerm Biotechnology for its「Golden Future Lutein Compound Liquid Capsule Bright Plus」及「"Golden Future Magic Reds Natto Monascus Capsule」for winning the gold and bronze medals in the 2022 Monde Selection® World Quality Evaluation Awards.

Awarding Invention Patent From the United States and Taiwan
Awarding Invention Patent From the United States and Taiwan
| 2022-01

Congratulate GeneFerm Biotechnology for its dual-effect immune function of "Ganoderma lucidum polysaccharides composite composition" after obtaining the invention patent of Taiwan, and then obtaining the affirmation of the US invention patent. It can be affirmed by multi-national patents and has a clear health effect verification, which can provide you with the most competitive powerful functional raw materials.More